Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial. Shares in the Anglo-US biotech rose sharply after ...
Incyte is preparing to take an oral JAK inhibitor into phase 3 trials for the skin depigmentation disease vitiligo, after reporting mid-stage data showing efficacy in patients with facial and ...
Scroll or swipe down to find out how to make a feast for the birds in your garden. There are three different bird feeders you can make with your grown-up. Take a look below, you might want to make all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback